|
rdfs:label
|
"Vedolizumab"@de
"Vedolizumab"@es
"Vedolizumab"@it
"Vedolizumab"@ru
"Vedolizumab"@tr
"Vedolizumabe"@pt
"vedolizumab"@ca
"vedolizumab"@en
"vedolizumab"@fr
"vedolizumab"@nn
"vedolizumab"@ro
"vedolizumab"@sl
"Ведолізумаб"@uk
"ודוליזומאב"@he
"فيدوليزوماب"@ar
"ଭେଡୋଲିଜୁମାବ"@or
"ベドリズマブ"@ja
"維得利珠單抗"@zh
"베돌리주맙"@ko
|
|
skos:altLabel
|
"LDP-02"@en
"MLN-0002"@en
"MLN-02"@en
"ଏଣ୍ଟିଭିଓ"@or
|
|
schema:description
|
"Antikörper"@de
"chemická sloučenina"@cs
"chemische verbinding"@nl
"component quimic"@oc
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"konposatu kimiko"@eu
"medicamento"@pt
"monoklonsko protitelo; biološko zdravilo"@sl
"pharmaceutical drug"@en
"związek chemiczny"@pl
"քիմիական միացություն"@hy
"תרכובת"@he
"دواء"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଏହା ମଧ୍ୟମରୁ ଗୁରୁତର ଅଲସରେଟିଭ କୋଲାଇଟିସ କିମ୍ବା କ୍ରନ୍ ରୋଗର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ଯାହା ଅନ୍ୟ କୌଣସି ଚିକିତ୍ସାରେ ଉପଶମ ହୁଏ ନାହିଁ ।"@or
|
|
schema:dateModified
|
"2026-11-04T17:28:57+00:00"^^xsd:dateTime
|
|
schema:version
|
2564773769
|
|
wikibase:identifiers
|
17
|
|
wikibase:sitelinks
|
14
|
|
wikibase:statements
|
31
|
|
p:P10245
|
wd:statement/Q7918002-9bab80c8-4863-d58b-30a9-59b1da7ec432
|
|
p:P10283
|
wd:statement/Q7918002-F241E03D-0FBC-465F-913E-FCBB4F65A990
|
|
p:P11143
|
wd:statement/Q7918002-D8516E80-62C7-4365-AD81-E920B55AF619
|
|
p:P1552
|
wd:statement/Q7918002-D405D67E-90F4-4F3C-A0C3-137059A68496
|
|
p:P2115
|
wd:statement/Q7918002-7B7DAEDA-B8D0-419C-AE45-FB604161D54E
|
|
p:P2175
|
wd:statement/Q7918002-2008B33E-7364-4B48-9057-DED883857060
|
|
wd:statement/Q7918002-312F7620-03C8-4CBB-A0AD-A64DBAAAB04A
|
|
wd:statement/Q7918002-5C7E3099-39D3-4DF4-A0B2-C7ABFD090038
|
|
p:P2275
|
wd:statement/Q7918002-BC30A708-A5D3-4CA5-B7E1-E94C026443D4
|
|
p:P231
|
wd:statement/Q7918002-0181F7E9-AA8C-4C30-9B17-8766B66E7839
|
|
p:P267
|
wd:statement/Q7918002-BF3751AA-BA7F-4D56-A51D-1408BE64773F
|
|
p:P279
|
wd:statement/Q7918002-5A41019E-1D46-409A-9CD0-0D53E9BFBB30
|
|
p:P2868
|
wd:statement/Q7918002-6EB3B127-B8FC-430E-8218-A62810532AE5
|
|
wd:statement/Q7918002-CFEFEFE1-F08E-40D0-984F-0117EDBD4EBF
|
|
p:P2892
|
wd:statement/Q7918002-4E85DE07-65E6-4498-9495-5A5657E8233C
|
|
p:P31
|
wd:statement/Q7918002-23AD3187-40F7-406F-845D-764A79E6366F
|
|
p:P3345
|
wd:statement/Q7918002-18BCDD79-C62D-488F-80D6-5C7C5D0926CF
|
|
p:P3350
|
wd:statement/Q7918002-67cde6a4-440d-f221-d96a-2fde5afea965
|
|
p:P3489
|
wd:statement/Q7918002-034F7F58-784D-4B19-BE3F-FE0954CCFE2E
|
|
p:P366
|
wd:statement/Q7918002-7DF80544-0705-42DF-8E72-1BACD1EF7934
|
|
p:P3780
|
wd:statement/Q7918002-7D822A0B-0625-41BF-9151-FA26A16051EB
|
|
p:P4250
|
wd:statement/Q7918002-8AF82D7D-1DC1-4E5D-ADDD-86E0A90E6AF0
|
|
p:P486
|
wd:statement/Q7918002-9DDD1DE2-42D2-4E79-BB20-D1722967CBA4
|
|
p:P527
|
wd:statement/Q7918002-7267986B-9F2A-4EBB-A03B-6E717E10FA98
|
|
p:P592
|
wd:statement/Q7918002-4B5F9FA0-2F61-42D7-A749-8929A072751C
|
|
p:P595
|
wd:statement/Q7918002-2d6b00b1-46bb-724a-23a8-6df576186acf
|
|
p:P6366
|
wd:statement/Q7918002-BA28F5C5-3DF2-4C22-A987-4BEF34F634F1
|
|
p:P646
|
wd:statement/Q7918002-BEC571D1-7163-46AE-9F47-11B10F746F08
|
|
p:P652
|
wd:statement/Q7918002-93B79147-EBB4-453A-94C5-E8087A41ABA7
|
|
p:P665
|
wd:statement/Q7918002-9CABF95E-93D9-4D77-9499-EDE87815A3FA
|
|
p:P715
|
wd:statement/Q7918002-290DF050-C910-4419-8323-9D74EBCA71EE
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000190759>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/C543529>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1743087>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2776207728>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D08083>
|
|
wdt:P10245
|
"a614034"
|
|
wdt:P10283
|
"C2776207728"
|
|
wdt:P11143
|
"Vedolizumab"
|
|
wdt:P1552
|
biopharmaceutical
|
|
wdt:P2115
|
"N0000190759"
|
|
wdt:P2175
|
graft-versus-host disease
|
|
ulcerative colitis
|
|
colitis
|
|
wdt:P2275
|
"vedolizumab"@en
|
|
wdt:P231
|
"943609-66-3"
|
|
wdt:P267
|
"L04AA33"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2868
|
monoclonal antibody
|
|
gastrointestinal agent
|
|
wdt:P2892
|
"C2607726"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3345
|
"1538097"
|
|
wdt:P3350
|
"9093"
|
|
wdt:P3489
|
US pregnancy category B
|
|
wdt:P366
|
medication
|
|
wdt:P3780
|
Entyvio
|
|
wdt:P4250
|
5.4^^xsd:decimal
|
|
wdt:P486
|
"C543529"
|
|
wdt:P527
|
carbon
|
|
wdt:P592
|
"CHEMBL1743087"
|
|
wdt:P595
|
"7437"
|
|
wdt:P6366
|
"2776207728"
|
|
wdt:P646
|
"/m/04q0jnv"
|
|
wdt:P652
|
"9RV78Q2002"
|
|
wdt:P665
|
"D08083"
|
|
wdt:P715
|
"DB09033"
|